Lund University Cancer Centre – Clinical Trials and Diagnostics Meeting
Dear all of LUCC, SUHCCC, and the local cancer-related life science community:
We welcome you to the third meeting of the LUCC network, LUCC Clinical Trials and Diagnostics, devoted to sharing expertise and experiences in running clinical trials and connected translational biomarker studies.
Save the date!
LUCC – Clinical Trials and Diagnostics Meeting
Day: 3 June 2026
Time: 13:00 – 16:00
Location: Lund – BMC – A: Segerfalksalen
Register here: https://survey.mailing.lu.se/lucc-ctad-june3
Anyone working within cancer and clinical trials and diagnostics is welcome, including industry.
On the agenda:
-Welcome (Lao Saal, Mats Jerkeman)
-Speakers
- Niklas Landberg (SUS/LU) – Targeting SLAMF6 in acute myeloid leukemia
- Niklas Loman (SUS/LU) – NordicTrip randomized phase III trial in triple-negative breast cancer
- Ingrid Teige (BioInvent) – BI-1808, a TNFR2 blocker/depleter, for T cell lymphoma
- Lao Saal (LU) – NeoCircle prospective breast cancer ctDNA biomarker observational study
- Karin Jirström (SUS/LU) – BILLIONSTARS prospective bile duct and liver cancer observational study
-Discussion of future LUCC-CTaD activities
-Lots of time for discussions.
Please register so we can plan the fika and coffee/tea accordingly.
– Mats & Lao